Intended for healthcare professionals

Letters Breakthrough cancer pain

Morphine remains gold standard in breakthrough cancer pain

BMJ 2008; 337 doi: (Published 24 December 2008) Cite this as: BMJ 2008;337:a3104
  1. Vicente Ruiz-Garcia1,
  2. Eduardo Lopez-Briz1
  1. 1Home Hospitalisation Unit, HU La Fe, 46014 Valencia, Spain
  1. ruiz_vicgar{at}

    Although Davies and colleagues argue that little evidence supports the unlicensed use of oral morphine,1 morphine remains the gold standard in cancer pain. Licensed or unlicensed use is a transient status, especially in palliative care. Little evidence may support the use of oral …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription